Dermatop and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Dermatop (prednicarbate), especially for people who are female, 10-19 old, have been taking the drug for 6 - 12 months also take Claravis, and have Asteatosis.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Dermatop. It is created by eHealthMe based on reports of 354 people who have side effects when taking Dermatop from the FDA, and is updated regularly.

What is Dermatop?

Dermatop has active ingredients of prednicarbate. eHealthMe is studying from 356 Dermatop users. Check the latest studies of Dermatop.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,492 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

On Jul, 14, 2026

354 people reported to have side effects when taking Dermatop.
Among them, 19 people (5.37%) have Visual acuity reduced.

Could Dermatop cause Visual acuity reduced?

Among these 19 people:

How long have people been on Dermatop when they have Visual acuity reduced? *

What is the gender of people who have Visual acuity reduced when taking Dermatop? *

female: 94.44 %
male: 5.56 %

What is the age of people who have Visual acuity reduced when taking Dermatop? *

What are other drugs people take besides Dermatop? *

What are other side effects people have besides Visual acuity reduced? *

Depression: 17 people, 89.47%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 17 people, 89.47%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 17 people, 89.47%
Indigestion: 17 people, 89.47%
Nausea And Vomiting: 17 people, 89.47%
Nosebleed (bleeding from nose): 17 people, 89.47%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 17 people, 89.47%
Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs): 17 people, 89.47%
Pleurisy (inflammation of the pleurae, which causes pain when breathing): 17 people, 89.47%
Pneumonia: 17 people, 89.47%

What are the existing conditions these people have? *

Lip Disorder (disease of lip): 14 people, 73.68%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 14 people, 73.68%
Asteatosis (any disease that persistently causes the skin to dry): 14 people, 73.68%
Folliculitis (infection of hair root): 6 people, 31.58%
Dry Eyes (lack of adequate tears): 2 people, 10.53%
Cheilitis (infection of lips): 2 people, 10.53%
Acne Cystic (skin problems that cause pimples): 2 people, 10.53%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 1 person, 5.26%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.26%
Hyperplasia (enlargement of an organ or tissue): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Dermatop and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dermatop:

Dermatop (356 reports)

Browse all side effects of Dermatop:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,492 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,887 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednicarbate (the active ingredients of Dermatop) and Dermatop (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.